Advertisement
Screener

NOMAD POWER SOLUTIONS, INC. (NMAD) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

1.5 / 5 stars · 15/50 Roast Me

NOMAD POWER SOLUTIONS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

NOMAD POWER SOLUTIONS, INC. (NMAD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 631.49 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-03-31

  • NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-12-31 was 50.00K shares.
  • NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-09-30 was 450.00K shares, a 1142.51% increase year-over-year.
  • NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-06-30 was 82.65K shares.
  • NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-03-31 was 48.85K shares.
  • NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 631.49K shares, a 580.38% increase from fiscal 2024.
  • NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 92.81K shares, a 67.99% decline from fiscal 2023.
  • NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 290.00K shares, a 75.76% increase from fiscal 2022.
  • NOMAD POWER SOLUTIONS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 165.00K shares, a 88.21% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 1 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month as first filedShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month as first filed
2025-12-3150.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
500.00K shares
derived: sum of 2 quarters · filed 2026-03-31
582.65K shares
derived: sum of 3 quarters · filed 2026-03-31
631.49K shares
10-K · filed 2026-03-31
2025-09-30450.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
532.65K shares
derived: sum of 2 quarters · filed 2025-11-12
581.49K shares
10-Q · filed 2025-11-12
581.49K shares
derived: sum of 4 quarters · filed 2026-03-31
2025-06-3082.65K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
131.49K shares
10-Q · filed 2025-08-07
131.49K shares
derived: sum of 3 quarters · filed 2026-03-31
167.71K shares
derived: sum of 4 quarters · filed 2026-03-31
2025-03-3148.85K shares
10-Q · filed 2025-05-12
48.85K shares
derived: sum of 2 quarters · filed 2026-03-31
85.06K shares
derived: sum of 3 quarters · filed 2026-03-31
2024-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
36.22K shares
derived: sum of 2 quarters · filed 2026-03-31
92.81K shares
10-K · filed 2026-03-31
2024-09-3036.22K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
92.81K shares
10-Q · filed 2024-11-12
2024-06-3056.60K shares
10-Q · filed 2024-08-08
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
250.00K shares
derived: sum of 2 quarters · filed 2025-03-24
290.00K shares
10-K · filed 2025-03-24
2023-09-30250.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
290.00K shares
10-Q · filed 2023-11-09
2023-06-3040.00K shares
10-Q · filed 2023-08-09
2022-12-31-585.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
-585.00K shares
derived: sum of 2 quarters · filed 2024-03-19
165.00K shares
10-K · filed 2024-03-19
1.65M shares
10-K · filed 2023-03-29
2022-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
750.00K shares
10-Q · filed 2022-11-08
2022-06-30750.00K shares
10-Q · filed 2022-08-10
2021-12-31200.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
200.00K shares
derived: sum of 2 quarters · filed 2023-03-29
1.20M shares
derived: sum of 3 quarters · filed 2023-03-29
1.40M shares
10-K · filed 2023-03-29
2021-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
1.00M shares
derived: sum of 2 quarters · filed 2021-11-10
1.20M shares
10-Q · filed 2021-11-10
200.00K shares
derived: sum of 4 quarters · filed 2022-03-21
2021-06-301.00M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
1.20M shares
10-Q · filed 2021-08-10
200.00K shares
derived: sum of 3 quarters · filed 2022-03-21
2021-03-31200.00K shares
10-Q · filed 2021-05-12
-800.00K shares
derived: sum of 2 quarters · filed 2022-03-21
2020-12-31-1.00M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21
200.00K shares
10-K · filed 2022-03-21
2020-09-301.20M shares
10-Q · filed 2020-11-10
2019-12-31-666.67K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26
-166.67K shares
derived: sum of 2 quarters · filed 2021-03-26
133.33K shares
10-K · filed 2021-03-26
800.00K shares
10-K · filed 2020-03-25
2019-09-30500.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
800.00K shares
10-Q · filed 2019-11-08
2019-06-30300.00K shares
10-Q · filed 2019-08-06
2018-12-31400.00K shares
10-K · filed 2020-03-25
2016-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29
500.00K shares
derived: sum of 2 quarters · filed 2017-03-29
1.40M shares
10-K · filed 2017-03-29
2016-09-30500.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
1.40M shares
10-Q · filed 2016-11-04
2016-06-30900.00K shares
10-Q · filed 2016-08-10
2015-12-31200.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29
1.20M shares
derived: sum of 2 quarters · filed 2017-03-29
1.70M shares
10-K · filed 2017-03-29
2015-09-301.00M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10
1.50M shares
10-Q · filed 2015-11-10
2015-06-30500.00K shares
10-Q · filed 2015-08-07
2014-12-31200.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28
200.00K shares
derived: sum of 2 quarters · filed 2016-03-28
700.00K shares
derived: sum of 3 quarters · filed 2016-03-28
4.70M shares
10-K · filed 2016-03-28
2014-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
500.00K shares
derived: sum of 2 quarters · filed 2014-11-12
4.50M shares
10-Q · filed 2014-11-12
4.60M shares
derived: sum of 4 quarters · filed 2015-03-27
2014-06-30500.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
4.50M shares
10-Q · filed 2014-08-08
4.60M shares
derived: sum of 3 quarters · filed 2015-03-27
4.60M shares
derived: sum of 4 quarters · filed 2015-03-27
2014-03-314.00M shares
10-Q · filed 2014-05-09
4.10M shares
derived: sum of 2 quarters · filed 2015-03-27
4.10M shares
derived: sum of 3 quarters · filed 2015-03-27
4.10M shares
derived: sum of 4 quarters · filed 2015-03-27
2013-12-31100.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27
100.00K shares
derived: sum of 2 quarters · filed 2015-03-27
100.00K shares
derived: sum of 3 quarters · filed 2015-03-27
100.00K shares
10-K · filed 2015-03-27
2013-09-300.00 shares
10-Q · filed 2013-11-07
0.00 shares
derived: sum of 2 quarters · filed 2013-11-07
0.00 shares
10-Q · filed 2013-11-07
1.13M shares
derived: sum of 4 quarters · filed 2014-03-21
2013-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05
0.00 shares
10-Q · filed 2013-08-05
1.13M shares
derived: sum of 3 quarters · filed 2014-03-21
1.15M shares
derived: sum of 4 quarters · filed 2014-03-21
2013-03-310.00 shares
10-Q · filed 2013-05-09
1.13M shares
derived: sum of 2 quarters · filed 2014-03-21
1.15M shares
derived: sum of 3 quarters · filed 2014-03-21
2012-12-311.13M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
1.15M shares
derived: sum of 2 quarters · filed 2014-03-21
1.20M shares
10-K · filed 2014-03-21
2012-09-3024.58K shares
10-Q · filed 2013-11-07
73.19K shares
10-Q · filed 2013-11-07
1.20M shares
10-Q · filed 2012-11-13
2012-06-300.00 shares
10-Q · filed 2012-08-10
2011-12-31950.00K shares
10-K · filed 2013-03-15
2011-06-30200.00K shares
10-K · filed 2014-03-21
2011-05-31200.00K shares
10-K · filed 2014-03-21
2006-06-3050.00K shares
10-Q · filed 2013-11-07
500.00K shares
10-Q · filed 2013-08-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
TALPHERA, INC. (TLPH)United States$0.060B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Xilio Therapeutics, Inc. (XLO)United States$0.052B